Navigation Links
Vaccine shows promise in preventing mono
Date:12/10/2007

A new study suggests that a vaccine targeting Epstein-Barr virus (EBV) may prevent infectious mononucleosis, commonly known as mono or glandular fever. The study is published in the December 15 issue of The Journal of Infectious Diseases, now available online.

EBV is a member of the herpes virus family and one of the most common viruses in humans, with nearly all adults in developed countries such as the United States having been infected. EBV is often asymptomatic but commonly causes infectious mononucleosis, with 30 to 40 percent of adolescents who contract the virus developing the disease. EBV is also associated with a number of other diseases, some of the most serious being lymphomas and other lymphoproliferative diseases in people with compromised immune systems, such as transplant patients. Despite the frequency of EBV infections and infectious mononucleosis, the new study is the first to suggest the efficacy of a vaccine in preventing infectious mononucleosis.

The study was conducted by Etienne M. Sokal, MD, PhD, and colleagues at several Belgian institutions and pharmaceutical companies. The vaccine targets glycoprotein 350, a protein that facilitates the entry of EBV into immune system cells. In this preliminary, Phase II clinical trial, 181 young adults who had not previously been infected by EBV received three doses of either a placebo or the vaccine.

During the 18-month observation period, the proportion of symptomatic EBV infections was reduced from 10 percent (nine out of 91) in the control group to 2 percent (two out of 90) in the vaccinated group, indicating that those who did not receive the vaccine were almost 5 times more likely to develop infectious mononucleosis.

With these promising results in a small group of subjects, Dr. Sokal suggested the next step should be large-scale studies on the benefit in healthy subjects and ability to prevent acute EBV infection and post-transplant lymphoprolifer
'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... August 31, 2014 LabDoor.com tests the ... and supplements. According to their website, “We buy products ... through retail stores and online sites. No manufacturer-supplied samples ... to “Stay Healthy with LabDoor,” a recent study was ... supplements in the United States for Vitamin D3 ...
(Date:8/31/2014)... August 31, 2014 Asked to ... difference between "Bioavailability" and "absorption," Dr. Priya Khan, ... with great interest. "Bioavailability" and "absorption" are ... in the supplement industry, second perhaps only to ... Bioavailability and absorption, while related, are not the ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Tickets for Brazil ... available at Ticket Down. This is great news for diehard ... the World Cup. To the delight of soccer fans in ... the MetLife Stadium on Tuesday, September 9th. , MetLife ... and New York Jets of the National Football League. The venue ...
(Date:8/31/2014)... NutriGold announces that its whole-food ... and berries, has been approved by ConsumerLab ... purity and label claims. , Most commercially ... genetically modified and chemically produced corn glucose through ... the use of a genetically modified microbe species ...
(Date:8/31/2014)... 2014 Recently, iFitDress.com, a well-known wedding dress ... gorgeous bridesmaid dresses for 2014. What’s more, the firm ... beautiful outfits; all people can enjoy a low rate (up ... valid from this afternoon until September 12. , “We ... outfits for customers from home and abroad. The main purpose ...
Breaking Medicine News(10 mins):Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 3Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 4Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at the MetLife Stadium 2Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 2Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 3Health News:Gorgeous Bridesmaid Dresses For 2014 Now Offered By iFitDress.com 2
... ordered to pay restitution of $2.3 billion and forfeit ... Financial Enterprises (NCFE) executives were sentenced today for their ... financial health of NCFE, Acting Assistant Attorney General Rita ... the Southern District of Ohio announced. NCFE, formerly based ...
... Economic Impact of Biopharmaceutical and Related Sectors to Be Released in ... Dover on Tuesday, March 31 DOVER, ... by We Work for Health - Delaware: WHAT : ... unique new statewide coalition of Delaware,s top leaders in business, ...
... at Princeton ( http://www.princetonhcs.org ) ... -- emergency, inpatient and neonatal intensive care -- through ... (CHOP).(Photo: http://www.newscom.com/cgi-bin/prnh/20090327/NY90350 )CHOP, ... in the world, is ranked first overall in the ...
... to be met by 2012CINCINNATI, March 27, 2009 ... PG ) today announced significantly increased targets ... reflect the company,s continued commitment and progress in ... operations and bettering lives of children in need ...
... 27 The Kroger Co. (NYSE: KR ... Pistachios sold in its family of retail stores because ... the following names in the 31 states where Kroger ... Fred Meyer, Fry,s, King Soopers, Smith,s, Dillons, QFC, City ...
... buildup, experts explain, , , FRIDAY, March 27 (HealthDay News) ... after breast cancer treatment, a new report shows. , ... who have their lymph nodes removed or radiated as ... National Cancer Institute. The swelling condition -- which can ...
Cached Medicine News:Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 2Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 3Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 4Health News:Business, Labor, Academia and Bioscience Groups to Launch New Coalition to Promote Medical Innovation and Spark Economic Growth 2Health News:Business, Labor, Academia and Bioscience Groups to Launch New Coalition to Promote Medical Innovation and Spark Economic Growth 3Health News:Business, Labor, Academia and Bioscience Groups to Launch New Coalition to Promote Medical Innovation and Spark Economic Growth 4Health News:University Medical Center at Princeton to Enhance Pediatric Care Through Agreement with The Children's Hospital of Philadelphia 2Health News:Procter & Gamble Deepens Corporate Commitment to Sustainability 2Health News:Procter & Gamble Deepens Corporate Commitment to Sustainability 3Health News:Kroger Recalls Shelled Pistachios Due to Possible Health Risk 2Health News:Microsurgery May Cut Swelling After Breast Cancer Treatment 2
(Date:8/29/2014)... The Competitive Intelligence (CI) function is evolving ... leaders who adjust will succeed, and those who don,t ... Practices, LLC study CI leaders from 32 biopharmaceutical organizations ... - Use secondary research whenever possible - it,s effective, ... Internal staff who are creative thinkers provide the CI ...
(Date:8/29/2014)... , Aug. 29, 2014   Mast ... biopharmaceutical company, announced today that Santosh Vetticaden, Chief ... leaving the Company, for personal reasons, in mid-September.  ... Medical Officer of Aires Pharmaceuticals, which Mast acquired ... responsibilities as the Company,s interim Chief Medical Officer.  ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Orthopedic Instrument Industry Report, 2014-2017" report to their ... and rising proportion of reimbursement for medical expenses, the ... with its scale presenting a CAGR of 19.2% during ... three product segments of orthopedic instruments in ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2
... Mylan Inc. (Nasdaq: MYL ) today announced ... the company has declared its quarterly dividend of $16.25 per ... a liquidation preference of $1,000.00 per share) payable on Nov. ... of Nov. 1, 2010.  Nov. 15, is also the date ...
... Reportlinker.com announces that a new market research report ... Renal Cell Carcimona Cancer Drug Futures ... EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET ... Carcinoma Cancer Drug Futures includes formats to meet ...
Cached Medicine Technology:Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 2Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 3Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 4Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 5Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 6Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 7Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 8Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 9
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
... coaxially on the loupe bar and is ... 4 hours continuous use. The K-L.E.D. comes ... unit that can hold and charge both ... convenient container to keep loupes when not ...
The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen...
Inquire...
Medicine Products: